companydata.dkcompanydata.dk

Abbott Rapid Diagnostics A/S: Financial statements 2019

CVR: 24204650

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Abbott Rapid Diagnostics A/S (CVR 24204650) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 15,279,289 and a net result of DKK 2,839,786 compared with DKK 983,465 the year before. That is an increase of 2.2% compared with the year before. Equity in the 2019 report amounted to DKK 27,431,355. The solvency ratio was 81.9%. The company had 17 employees in the financial year.

Gross Profit
DKK 15,279,289
Profit/Loss
DKK 2,839,786
Equity
DKK 27,431,355
Total Assets
DKK 33,487,560
Employees
17

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-15.3 mio.2.8 mio.27.4 mio.17
2018-14.9 mio.983 t.24.6 mio.19
2017-18.2 mio.99 t.23.6 mio.23
2016-18.7 mio.-330 t.23.5 mio.21
2015-23.4 mio.4.1 mio.23.8 mio.22

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Petter Aspaas joins the board of Abbott Rapid Diagnostics A/SOct 21, 2019

As of October 21, 2019, Petter Aspaas has joined the board of directors of Abbott Rapid Diagnostics A/S.

Thor Harald Kløver joins the board of Abbott Rapid Diagnostics A/SOct 21, 2019

As of October 21, 2019, Thor Harald Kløver has joined the board of directors of Abbott Rapid Diagnostics A/S.

Tomas Dan-Ola Blomqvist leaves the board of Abbott Rapid Diagnostics A/SOct 21, 2019

As of October 21, 2019, Tomas Dan-Ola Blomqvist has left the board of directors of Abbott Rapid Diagnostics A/S.

Petter Aspaas leaves the board of Abbott Rapid Diagnostics A/SOct 20, 2019

As of October 20, 2019, Petter Aspaas has left the board of directors of Abbott Rapid Diagnostics A/S.

ALERE A/S changes name to Abbott Rapid Diagnostics A/SOct 1, 2019

On October 1, 2019, the company changed its name from ALERE A/S to Abbott Rapid Diagnostics A/S.

Abbott Rapid Diagnostics A/S: The 2018 annual report is outJun 28, 2019

Abbott Rapid Diagnostics A/S has published its annual report for 2018. Gross profit came to DKK 14,948,878, and the net result was DKK 983,465.

Abbott Rapid Diagnostics A/S appoints new auditorMay 8, 2019

As of May 8, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of Abbott Rapid Diagnostics A/S.

Auditor steps down at Abbott Rapid Diagnostics A/SMay 8, 2019

As of May 8, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Abbott Rapid Diagnostics A/S.

About Abbott Rapid Diagnostics A/S

Abbott Rapid Diagnostics A/S is a Danish company of the type Aktieselskab based in København S, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ALERE A/S and MEDINOR A/S. The management consists of Berit Landsend-Holo. The board consists of Fredrik Björn Anders Björnulfson (chair), Berit Landsend-Holo and Mark Andrew Koewler. The company is owned by St. Jude Medical International Holding. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,286,557 and a net result of DKK 561,997 compared with DKK 854,423 the year before. Equity in the 2025 report amounted to DKK 32,222,511.

Source: annual report 2025, Danish Business Authority